HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 295 filers reported holding HAEMONETICS CORP in Q3 2018. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $3,452,000 | -37.6% | 38,493 | -49.1% | 0.04% | -40.3% |
Q1 2018 | $5,531,000 | +13.7% | 75,605 | -9.7% | 0.06% | +21.6% |
Q4 2017 | $4,863,000 | +21.5% | 83,734 | -6.1% | 0.05% | +15.9% |
Q3 2017 | $4,001,000 | +15.3% | 89,178 | +1.5% | 0.04% | +12.8% |
Q2 2017 | $3,470,000 | -2.3% | 87,858 | +0.3% | 0.04% | -4.9% |
Q1 2017 | $3,553,000 | -3.1% | 87,589 | -4.0% | 0.04% | -12.8% |
Q4 2016 | $3,668,000 | +17.5% | 91,245 | +5.9% | 0.05% | -11.3% |
Q3 2016 | $3,121,000 | +25.0% | 86,179 | +0.1% | 0.05% | +17.8% |
Q2 2016 | $2,496,000 | -22.1% | 86,106 | -6.0% | 0.04% | -25.0% |
Q1 2016 | $3,204,000 | +5.4% | 91,599 | -2.9% | 0.06% | +9.1% |
Q4 2015 | $3,041,000 | -78.4% | 94,315 | -78.4% | 0.06% | -80.0% |
Q3 2015 | $14,082,000 | -19.7% | 435,714 | +2.8% | 0.28% | -14.9% |
Q2 2015 | $17,539,000 | -4.0% | 424,049 | +4.2% | 0.32% | -6.6% |
Q1 2015 | $18,276,000 | +15.9% | 406,866 | -3.5% | 0.35% | +9.8% |
Q4 2014 | $15,775,000 | – | 421,571 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |